Trends in Nasopharyngeal Carcinoma Mortality in China, 1973-2005 |
Huang, Tian-Ren
(Department of Epidemiology, Guangxi Cancer Institute)
Zhang, Si-Wei (National Office for Cancer Prevention and Control, Ministry of Health) Chen, Wan-Qing (National Office for Cancer Prevention and Control, Ministry of Health) Deng, Wei (Department of Epidemiology, Guangxi Cancer Institute) Zhang, Chun-Yan (Department of Epidemiology, Guangxi Cancer Institute) Zhou, Xin-Juan (Department of Epidemiology, Guangxi Cancer Institute) Zhai, Ri-Hong (Department of Environmental Health, Harvard School of Public Health) |
1 | National Center of Health Information and Statistics (NCHIS) (1999). Annual report for national health information and statistics. Beijing, P.R. China, 1999. |
2 | National Office for Cancer prevention and Control (NOCPC) (2008). Survey of Cancer Mortality in China (1990 - 1992). People's Health Publishing House. P.1-629. |
3 | Ou SH, Zell JA, Ziogas A (2007). Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol, 18, 29-35. DOI |
4 | Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
5 | Parkin DM,Whelan SL,Ferlay J, et al (1997). Cancer incidence in five continents.Vol 7. Lyon, France: International Agency for Research on Cancer, 334-7. |
6 | Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995). Clonal proliferations of cells infected with Epstein- Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med, 333, 693-8. DOI ScienceOn |
7 | Population Census Office (1982). National Bureau of Statistics. 1982 Population Census of China. China Statistics Press, Beijing. |
8 | Rischin D, Corry J, Smith J, et al (2002). Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol, 20, 1845-52. DOI |
9 | Spano JP, Busson P, Atlan D, et al (2003). Nasopharyngeal carcinomas: an update. Eur J Cancer, 39, 2121-35. DOI ScienceOn |
10 | The Editorial Committee (1979). Atlas of cancer mortality in the people's Republic of China. Shanghai, China Map Press. P. 1-99. |
11 | Anandan C, Elton R, Hitchings A, Brewster DH (2008). Nasopharyngeal cancer incidence and survival in Scotland, 1975-2001. Clin Otolaryngol, 33, 12-27. DOI |
12 | Banister J, Hill K (2004). Mortality in China 1964-2000. Popul Stud, 58, 55-75. DOI |
13 | Baujat B, Audry H, Bourhis J, et al (2006). MAC-NPC Collaborative Group. MAC-NPC Collaborative Group. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev, 6, CD004329. |
14 | Buell P (1974). The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res, 34, 1189-91. |
15 | Chan AT, Teo PM, Leung TW, Johnson PJ (1998). The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer, 82, 1003-12. DOI ScienceOn |
16 | Chang ET, Adami HO (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1765-77. DOI |
17 | Cheng Z (2008). Report on the third national retrospective deathcauses sampling survey in China. Peking Union Medical College Press, Beijing, 1-214. |
18 | Chien YC, Chen JY, Liu MY, Yang HI, et al (2001). Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med, 345, 1877-82. DOI ScienceOn |
19 | Dai XD, Li LD, Lu FZ (1999). Trend of China nasopharyngeal carcinoma in 20 years and its prediction in the near future. J Prac Oncol, 13, 1-5. |
20 | Deng H, Zeng Y, Lei Y, et al (1995). Serological survey of nasopharyngeal carcinoma in 21 cities of south China. Chin Med J, 108, 300-3. |
21 | Faggiano F, Partanen T, Kogevinas M, Boffetta P,et al (1997). Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ, 138, 65-176. |
22 | Guo X, Johnson RC, Deng H, Liao J, Guan L, et al (2009). Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer, 124, 2942-7. |
23 | Yang L, Parkin DM, Li L, Chen Y (2003). Sources of information on the burden of cancer in China. Asian Pac J Cancer Prev, 4, 23-30. |
24 | Waterhouse J, Muir C, Correa P, Powell J (1976). Cancer incidence in five continents. Lyon, IARC Sci Publ: 456. |
25 | Wei KR, Yu YL, Yang YY, et al (2010). Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev, 11, 29-32. |
26 | Wong CH, Kelly LE, Tripcony LB (2007). Nasopharygeal carcinoma in Queensland, Australia: a review of 10 years experience. Australia Radiol, 51, 276-82. DOI |
27 | Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer, 90, 2157-66. |
28 | Yang L, Parkin DM, Li L, Chen Y (2004). A comparison of the sources of cancer mortality in China. Cancer Causes Control, 15, 681-7. DOI ScienceOn |
29 | Yu MC, Ho JH, Lai SH, Henderson BE (1986). Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res, 46, 956-61. |
30 | Yu MC, Yuan JM (2002). Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 12, 421-9. DOI |
31 | Yu WM, Hussain SS (2009). Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review. J Laryngol Otol, 123, 1067-74. DOI |
32 | Zhang CQ, Zhong YS, Sun Y, et al (2004). The application of serum EBNA1- IgA and EA- IgG markers in early diagnosis of nasopharyngeal carcinoma. Chin J Oncol, 26, 482-4. |
33 | Kong L, Zhang YW (2008). Historical evolution in the diagnosis and treatment of nasopharyngeal carcinoma. China Oncol, 18, 641-7. |
34 | Huang TB, Wang HM, Li JL, et al (1997). Identification of high risk populations for nasopharyngeal carcinoma. Chin J Cancer, 16, 81-4. |
35 | Jia WH, Huang QH, Liao J, et al (2006). Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 6, 178. DOI |
36 | Jin F, Devesa SS, Chow WH, Zheng W, Ji BT,et al (1999). Gao YT. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer, 83,435-40. DOI |
37 | La Vecchia C, Negri E, Levi F, Decarli A, Boyle P (1998). Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer, 34, 118-41. DOI |
38 | Lee AW, Foo W, Mang O, et al (2003). Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer, 103, 680-5. DOI |
39 | Lee JT, Ko CY (2005). Has survival improved for nasopharyngeal carcinoma in the United States? Otolaryngol Head Neck Surg, 132, 303-8. DOI |
40 | Li LD, Lu FZ, Zhang SW, et al (1996). Analysis of cancer mortality and distribution in China from year 1990 through 1992. An epidemiologic study. Chin J Oncol, 18, 403-7. |
41 | Lu TX (2009). Diagnosis and treatment of nasopharyngeal carcinoma: 30 years of change and progress in China. Chinese J Clinicians;3 (Electronic Version). |
42 | National Office for Cancer prevention and Control (NOCPC) (1979). Investigation of Cancer Mortality in China. People's Health Publishing House, 1979. |
43 | Zhou YS, Zhang SW, Li LD (1997). Analysis for death for all and malignant tumors for Chinese population. Bull Chin Can, 6, 9-11. |
44 | Zhang SW, Chen WQ, Wei WQ, Li GL, Li N (2010). Ovary cancer mortality in China 2004 - 2005: results from the Third National Retrospective Sampling Survey of Death Causes. Chin J Prev Med, 44, 418-22 |